Tag: Daewoong Pharmaceutical Co.

Daewoong Pharmaceutical Launches NABOTA in Qatar, Expands Presence in High-Potential GCC Aesthetic Market

DOHA, Qatar, June 12, 2025 /PRNewswire/ -- Daewoong Pharmaceutical has officially launched its high-purity, high-quality botulinum toxin, NABOTA, in Qatar—further reinforcing its strategy to...

Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics

- The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance Daewoong Pharmaceutical's drug...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsDaewoong Pharmaceutical Co.

Aker ASA: Presentation of Second-Quarter and Half-Year Results 2025

US $1,000 quick loan No Credit Check Loans: Radcred Launches Instant Bad Credit Loans For Emergency Need

JW Marriott Phu Quoc Unlocks a Season of Discovery with New Summer Offer

Tag: Daewoong Pharmaceutical Co.

Daewoong Pharmaceutical Launches NABOTA in Qatar, Expands Presence in High-Potential GCC Aesthetic Market

Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us